MedTrace Logo

Pediatric Caudal Dexmedetomidine Enhances Postoperative Analgesia of Magnesium Sulphate in Lower Abdominal Surgeries

NCT02487355 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2017-09-26

No results posted yet for this study

Summary

The study will conduct to compare the efficacy of Magnesium sulphate \& dexmedetomidine used as adjuvants to bupivacaine in caudal block to provide intra-operative anesthesia as well as post -operative analgesia in pediatric patients.

Conditions

  • Pain, Postoperative

Interventions

DRUG

Dexmedetomidine

Dexmedetomidine 1 μg/ kg

DRUG

Magnesium Sulphate

Magnesium Sulphate 50 mg

DRUG

Bupivacaine

1ml/kg of 0.25%of bupivacaine

DRUG

Dexmedetomidine + Magnesium Sulphate + Bupivacaine

Dexmedetomidine 1 μg/ kg + Magnesium Sulphate 50 mg + 1ml/kg of 0.25%of bupivacaine

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • jehan A Sayed, MD · assistant professor in anesthesia and intensive care department,faculty of medicine,Assiut univeristy,egypt

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
6 Months
Max Age
6 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02487355 on ClinicalTrials.gov